An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer
The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
The clinical development of an inhibitor of cellular proteasome function suggests that compounds targeting other components of the ubiquitin-proteasome system might prove useful for the treatment of human malignancies. NEDD8-activating enzyme (NAE) is an essential component of the NEDD8 conjugation pathway that controls the activity of the cullin-RING subtype of ubiquitin ligases, thereby regulating the turnover of a subset of proteins upstream of the proteasome. Substrates of cullin-RING ligases have important roles in cellular processes associated with cancer cell growth and survival pathways. Here we describe MLN4924, a potent and selective inhibitor of NAE. MLN4924 disrupts cullin-RING ligase-mediated protein turnover leading to apoptotic death in human tumour cells by a new mechanism of action, the deregulation of S-phase DNA synthesis. MLN4924 suppressed the growth of human tumour xenografts in mice at compound exposures that were well tolerated. Our data suggest that NAE inhibitors may hold promise for the treatment of cancer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“orthogonally confirmed dose-dependent KAT2A degradation by western blot, and demonstrated that this degradation can be rescued by pre-treatment with a UBA3/NAE1 inhibitor, MLN4924 (37), a proteasome inhibitor, bortezomib (38), and a competing CRBN ligand, pomalidomide (7) (Fig. 1D).”
From Degron-independent recruitment of KAT2A expands the target space of CRBN molecular glues (2026) · cites this paper as [37]
In the citing paper
“we cotreated cells with a proteasome inhibitor (bortezomib) or a NEDD8-activating enzyme E1 inhibitor (MLN-4924 32 ) and found that both inhibitors prevented degradation of BTK (Figure 2D).”
From Bruton tyrosine kinase degradation as a therapeutic strategy for cancer (2019) · cites this paper as [32]
Citations
Cites
Hershko, A., & Ciechanover, A. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.425 · Cited by 8,840
Rock, K. L., Gramm, C., Rothstein, L., Clark, K., Stein, R., Dick, L., Hwang, D., & Goldberg, A. L. (1994) · Cell · doi:10.1016/s0092-8674(94)90462-6 · Cited by 2,524
Self-citationKobayashi, A., Kang, M.-I., Okawa, H., Ohtsuji, M., Zenke, Y., Chiba, T., Igarashi, K., & Yamamoto, M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.16.7130-7139.2004 · Cited by 2,224
Function and regulation of cullin–RING ubiquitin ligases
Petroski, M. D., & Deshaies, R. J. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1547 · Cited by 2,148
SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27
Carrano, A. C., Eytan, E., Hershko, A., & Pagano, M. (1999) · Nature Cell Biology · doi:10.1038/12013 · Cited by 1,543
Modification of Proteins by Ubiquitin and Ubiquitin-Like Proteins
Kerscher, O., Felberbaum, R., & Hochstrasser, M. (2006) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.22.010605.093503 · Cited by 1,517
Winston, J. T., Strack, P., Beer-Romero, P., Chu, C. Y., Elledge, S. J., & Harper, J. W. (1999) · Genes & Development · doi:10.1101/gad.13.3.270 · Cited by 954
Duda, D. M., Borg, L. A., Scott, D. C., Hunt, H. W., Hammel, M., & Schulman, B. A. (2008) · Cell · doi:10.1016/j.cell.2008.07.022 · Cited by 767
Kamura, T., Sato, S., Iwai, K., Czyzyk-Krzeska, M., Conaway, R. C., & Conaway, J. W. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.190332597 · Cited by 653
Velcade®: U.S. FDA Approval for the Treatment of Multiple Myeloma Progressing on Prior Therapy
Kane, R. C., Bross, P. F., Farrell, A. T., & Pazdur, R. (2003) · The Oncologist · doi:10.1634/theoncologist.8-6-508 · Cited by 628
Cited by
Items 601–700 of 1,005
A Metal-Based Inhibitor of NEDD8-Activating Enzyme
Zhong, H., Yang, H., Chan, D. S., Leung, C., Wang, H., & Ma, D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049574 · Cited by 46
Twists and turns in ubiquitin‐like protein conjugation cascades
Schulman, B. A. (2011) · Protein Science · doi:10.1002/pro.750 · Cited by 53
Essential Role for IKKβ in Production of Type 1 Interferons by Plasmacytoid Dendritic Cells
Pauls, E., Shpiro, N., Peggie, M. W., Young, E. R. R., Sorcek, R. J., Tan, L., Choi, H. G., & Cohen, P. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.345405 · Cited by 46
Neddylation pathway regulates the proliferation and survival of macrophages
Li, L., Liu, B., Dong, T., Lee, H. W., Yu, J., Zheng, Y., Gao, H., Zhang, Y., Chu, Y., Liu, G., et al. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.02.028 · Cited by 46
Self-citationCalabrese, M. F., Scott, D. C., Duda, D. M., Grace, C. R., Kurinov, I. V., Kriwacki, R. W., & Schulman, B. A. (2011) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2086 · Cited by 50
Inhibition of CUL4A Neddylation Causes a Reversible Block to SAMHD1-Mediated Restriction of HIV-1
Hofmann, H., Norton, T. D., Schultz, M. L., Polsky, S. B., Sunseri, N., & Landau, N. R. (2013) · Journal of Virology · doi:10.1128/jvi.02002-13 · Cited by 46
Reinhard, C., Bottinelli, D., Kim, B., & Luban, J. (2014) · Retrovirology · doi:10.1186/1742-4690-11-12 · Cited by 46
McCormack, R., Lyapichev, K. A., Olsson, M. L., Podack, E. R., & Munson, G. P. (2015) · eLife · doi:10.7554/elife.06505 · Cited by 50
Small molecule activators of the p53 response
Ladds, M. J. G. W., & Laín, S. (2019) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjz006 · Cited by 49
Brief review on repurposed drugs and vaccines for possible treatment of COVID-19
De, P., Chakraborty, I., Karna, B., & Mazumder, N. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.173977 · Cited by 51
Zhao, L., Yue, P., Lonial, S., Khuri, F. R., & Sun, S. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0401 · Cited by 46
Olaizola, P., Lee, P. Y., Fernández‐Barrena, M. G., Alvarez, L., Cadamuro, M., Azkargorta, M., O’Rourke, C. J., Caballero-Camino, F. J., Olaizola, I., Macías, R. I. R., et al. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.02.007 · Cited by 47
Dynamic regulation of ubiquitin-dependent cell cycle control
Craney, A., & Rapé, M. (2013) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2013.07.004 · Cited by 45
A Mental Retardation-linked Nonsense Mutation in Cereblon Is Rescued by Proteasome Inhibition
Xu, G., Jiang, X., & Jaffrey, S. R. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.472092 · Cited by 50
Neddylation, a novel paradigm in liver cancer
Delgado, T. C., Barbier‐Torres, L., Zubiete‐Franco, I., Lopitz‐Otsoa, F., Varela‐Rey, M., Fernández‐Ramos, D., & Martínez‐Chantar, M. L. (2018) · Translational Gastroenterology and Hepatology · doi:10.21037/tgh.2018.06.05 · Cited by 46
Neddylation-Independent Activities of MLN4924
Mao, H., & Sun, Y. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-1025-0_21 · Cited by 45
The novel cereblon modulator CC-885 inhibits mitophagy via selective degradation of BNIP3L
Hao, B., Li, X., Jia, X., Wang, Y., Zhai, L., Li, D., Liu, J., Zhang, D., Chen, Y.-L., Xu, Y., et al. (2020) · Acta Pharmacologica Sinica · doi:10.1038/s41401-020-0367-9 · Cited by 47
Ho, I.-L., Kuo, K.-L., Liu, S., Chang, H., Hsieh, J., Wu, J., Chiang, C., Lin, W., Tsai, Y., Chou, C.-T., et al. (2015) · Scientific Reports · doi:10.1038/srep16948 · Cited by 46
Neddylation requires glycyl-tRNA synthetase to protect activated E2
Mo, Z., Zhang, Q., Liu, Z., Lauer, J. L., Shi, Y., Sun, L., Griffin, P. R., & Yang, X. (2016) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3250 · Cited by 45
Ubiquitination and Proteolysis in Acute Lung Injury
Vadász, I., Weiss, C. H., & Sznajder, J. I. (2012) · CHEST Journal · doi:10.1378/chest.11-1660 · Cited by 46
Gavin, J. M., Chen, J. J., Liao, H., Rollins, N., Yang, X., Xu, Q., Ma, J., Loke, H.-K., Lingaraj, T., Brownell, J. E., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.336198 · Cited by 44
Self-citationDNA Replication Stress and Cancer: Cause or Cure?
Taylor, E. M., & Lindsay, H. D. (2015) · Future Oncology · doi:10.2217/fon.15.292 · Cited by 49
The E3 ligase C-CBL inhibits cancer cell migration by neddylating the proto-oncogene c-Src
Lee, G. W., Park, J. B., Park, S. Y., Seo, J., Shin, S.-H., Park, J., Kim, S. J., Watanabe, M., & Chun, Y. (2018) · Oncogene · doi:10.1038/s41388-018-0354-5 · Cited by 46
Novel Therapeutics for Aggressive Non-Hodgkin's Lymphoma
Mahadevan, D., & Fisher, R. I. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.32.7171 · Cited by 44
H2O2 Regulates Lung Epithelial Sodium Channel (ENaC) via Ubiquitin-like Protein Nedd8
Downs, C. A., Kumar, A., Kreiner, L. H., Johnson, N. M., & Helms, M. N. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.389536 · Cited by 43
p53, SKP2, and DKK3 as MYCN Target Genes and Their Potential Therapeutic Significance
Chen, L., & Tweddle, D. A. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00173 · Cited by 47
Kabir, S., Cidado, J. R., Andersen, C. L., Dick, C., Lin, P., Mitros, T., Ma, H., Baik, R., Belmonte, M. A., Drew, L., et al. (2019) · eLife · doi:10.7554/elife.44288 · Cited by 45
Ferris, J., Espona‐Fiedler, M., Hamilton, C., Holohan, C., Crawford, N., McIntyre, A. J., Roberts, J. Z., Wappett, M., McDade, S. S., Longley, D. B., et al. (2020) · Cell Death Discovery · doi:10.1038/s41420-020-00296-w · Cited by 43
Current Status of SUMOylation Inhibitors
Brackett, C. M., & Blagg, B. S. J. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867327666200810135039 · Cited by 45
Cullin-5 neddylation-mediated NOXA degradation is enhanced by PRDX1 oligomers in colorectal cancer
Xu, S., Ma, Y., Tong, Q., Yang, J. J., Liu, J., Wang, Y., Li, G., Zeng, J., Fang, S., Li, F., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03557-3 · Cited by 46
Self-citationLiu, P., Cong, X., Liao, S., Jia, X., Wang, X., Dai, W., Zhai, L., Zhao, L., Ji, J., Ni, D., et al. (2021) · Cell Death and Differentiation · doi:10.1038/s41418-021-00827-7 · Cited by 44
Self-citationThe novel protective role of P27 in MLN4924-treated gastric cancer cells
Zhang, Q., Hou, D., Luo, Z., Chen, P., Lv, B., Wu, L., Ma, Y., Chu, Y., Liu, H., Liu, F., et al. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.215 · Cited by 43
Self-citationmTORC1 Dependent Regulation of REDD1 Protein Stability
Tan, C. Y., & Hagen, T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063970 · Cited by 44
Xu, W., Toth, J. I., da Silva, S. D., Paiva, S.-L., Lukkarila, J. L., Hurren, R., MacLean, N., Sukhai, M., Bhattacharjee, R., Goard, C., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0093530 · Cited by 38
Feng, J., Read, O. J., & Dinkova‐Kostova, A. T. (2023) · Molecules and Cells · doi:10.14348/molcells.2023.2183 · Cited by 43
Zheng, B., Qian, F., Wang, X., Wang, Y., Zhou, B., & Fang, L. (2024) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-024-03085-w · Cited by 48
Swords, R. T., Watts, J. M., Erba, H. P., Altman, J. K., Maris, M. B., Anwer, F., Hua, Z.-C., Stein, H., Faessel, H. M., Sedarati, F., et al. (2017) · Blood Cancer Journal · doi:10.1038/bcj.2017.1 · Cited by 44
Wang, X., Arceci, A., Bird, K. E., Mills, C. A., Choudhury, R., Kernan, J. L., Zhou, C., Bae-Jump, V. L., Bowers, A. A., & Emanuele, M. J. (2017) · Molecular and Cellular Biology · doi:10.1128/mcb.00609-16 · Cited by 46
CRL4Cdt2: Coupling Genome Stability to Ubiquitination
Παναγόπουλος, Α., Taraviras, S. L., Nishitani, H., & Lygerou, Z. (2020) · Trends in Cell Biology · doi:10.1016/j.tcb.2020.01.005 · Cited by 47
Minor, M., Hollinger, F. B., McNees, A. L., Jung, S. Y., Jain, A., Hyser, J. M., Bissig, K., & Slagle, B. L. (2020) · Cells · doi:10.3390/cells9040834 · Cited by 46
Who with whom: functional coordination of E2 enzymes by RING E3 ligases during poly‐ubiquitylation
Lips, C., Ritterhoff, T., Weber, A. J., Janowska, M. K., Mustroph, M., Sommer, T., & Klevit, R. E. (2020) · The EMBO Journal · doi:10.15252/embj.2020104863 · Cited by 45
Li, Y., Wang, C., Xu, T., Pan, P., Yu, Q., Xu, L., Xiong, X., Hou, T., Cui, S., & Sun, Y. N. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.07.012 · Cited by 43
DNA damage-induced activation of CUL4B targets HUWE1 for proteasomal degradation
Yi, J., Lu, G. X., Li, L., Wang, X., Cao, L., Lin, M. T., Zhang, S., & Shao, G. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv325 · Cited by 42
Lukkarila, J. L., da Silva, S. R., Ali, M., Shahani, V. M., Xu, G. W., Berman, J., Roughton, A. L., Dhe‐Paganon, S., Schimmer, A. D., & Gunning, P. T. (2011) · ACS Medicinal Chemistry Letters · doi:10.1021/ml2000615 · Cited by 42
Su, H., Li, J., Zhang, H., Ma, W., Wei, N., Liu, J., & Wang, X. (2015) · Circulation Research · doi:10.1161/circresaha.115.306783 · Cited by 42
Aldonza, M. B. D., Hong, J., Alinsug, M. V., Song, J., & Lee, S. K. (2016) · Oncotarget · doi:10.18632/oncotarget.9118 · Cited by 45
Ishikawa, Y., Nakayama, K., Morimoto, M., Mizutani, A., Nakayama, A., Toyoshima, K., Hayashi, A., Takagi, S., Dairiki, R., Miyashita, H., et al. (2017) · Oncogenesis · doi:10.1038/oncsis.2017.76 · Cited by 42
Chen, Z., Ioris, R. M., Richardson, S., Van Ess, A. N., Vendrell, I., Kessler, B. M., Buffa, F. M., Busino, L., Clifford, S. C., Bullock, A. N., et al. (2022) · Cell Death & Differentiation · doi:10.1038/s41418-022-00983-4 · Cited by 41
Substrate and Functional Diversity of Protein Lysine Post-translational Modifications
Hao, B., Chen, K., Zhai, L., Liu, M., Liu, B., & Tan, M. (2024) · Genomics Proteomics & Bioinformatics · doi:10.1093/gpbjnl/qzae019 · Cited by 47
The Emerging Role of the Ubiquitin Proteasome in Pulmonary Biology and Disease
Weathington, N. M., Sznajder, J. I., & Mallampalli, R. K. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201304-0754pp · Cited by 44
MLN4924 Is an Efficient Inhibitor of NEDD8 Conjugation in Plants
Hakenjos, J. P., Richter, R., Dohmann, E. M. N., Katsiarimpa, A., Isono, E., & Schwechheimer, C. (2011) · PLANT PHYSIOLOGY · doi:10.1104/pp.111.176677 · Cited by 44
Effects of dietary aflatoxin on the hepatic expression of apoptosis genes in growing barrows1
Rustemeyer, S. M., Lamberson, W. R., Ledoux, D. R., Wells, K. D., Austin, K. J., & Cammack, K. M. (2011) · Journal of Animal Science · doi:10.2527/jas.2010-3473 · Cited by 46
Nezames, C. D., & Deng, X. W. (2012) · PLANT PHYSIOLOGY · doi:10.1104/pp.112.198879 · Cited by 41
The role of PML ubiquitination in human malignancies
Chen, R., Lee, Y.-R., & Yuan, W.-C. (2012) · Journal of Biomedical Science · doi:10.1186/1423-0127-19-81 · Cited by 43
-TrCP and Casein Kinase III Mediated Degradation of Cyclin F Controls Timely Mitotic Entry
Mavrommati, I., Faedda, R., Galasso, G., Li, J., Burdová, K., Fischer, R., Kessler, B. M., Carrero, Z. I., Guardavaccaro, D., Pagano, M., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.08.076 · Cited by 41
Zhang, Q., Mady, A. S. A., Ma, Y., Ryan, C., Lawrence, T. S., Nikolovska‐Coleska, Z., Sun, Y. N., & Morgan, M. A. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz058 · Cited by 44
Gossypol inhibits cullin neddylation by targeting SAG-CUL5 and RBX1-CUL1 complexes
Yu, Q., Hu, Z., Shen, Y., Jiang, Y., Pan, P., Hou, T., Pan, Z., Huang, J., & Sun, Y. (2020) · Neoplasia · doi:10.1016/j.neo.2020.02.003 · Cited by 44
Liang, Y., Jiang, Y., Jin, X., Chen, P., Heng, Y., Cai, L., Zhang, W., Li, L., & Jia, L. (2020) · Cell Communication and Signaling · doi:10.1186/s12964-020-00576-z · Cited by 45
Neddylation, an Emerging Mechanism Regulating Cardiac Development and Function
Li, J., Zou, J., Littlejohn, R., Liu, J., & Su, H. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.612927 · Cited by 41
CUL2 LRR1 , TRAIP and p97 control CMG helicase disassembly in the mammalian cell cycle
Villa, F., Fujisawa, R., Ainsworth, J., Nishimura, K., Lie‐A‐Ling, M., Lacaud, G., & Labib, K. P. (2021) · EMBO reports · doi:10.15252/embr.202052164 · Cited by 41
Cojocari, D., Smith, B. N., Purkal, J. J., Arrate, M. P., Huska, J. D., Xiao, Y., Gorska, A. E., Hogdal, L. J., Ramsey, H. E., Boghaert, E. R., et al. (2021) · Haematologica · doi:10.3324/haematol.2020.272609 · Cited by 43
Xing, S., Nong, F., Wang, Y., Huang, D., Qin, J., Chen, Y., He, D., Wu, P., Huang, H., Zhan, R., et al. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106059 · Cited by 43
Zhang, S., You, X.-H., Xu, T., Chen, Q., Li, H., Dou, L., Sun, Y., Xiong, X., Meredith, M. A., & Sun, Y. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05292-9 · Cited by 43
Smith, M. A., Maris, J. M., Gorlick, R. G., Kolb, E. A., Lock, R. B., Carol, H., Keir, S. T., Reynolds, C. P., Kang, M. H., Morton, C. L., et al. (2011) · Pediatric Blood & Cancer · doi:10.1002/pbc.23357 · Cited by 44
Self-citationTracing the history of the ubiquitin proteolytic system: The pioneering article
Ciechanover, A. J. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.06.065 · Cited by 46
Regulation of TGF‐β signal transduction by mono‐ and deubiquitylation of Smads
Dupont, S., Inui, M., & Newfeld, S. J. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.03.037 · Cited by 43
Kanarek, N., Horwitz, E. P., Mayan, I., Leshets, M., Cojocaru, G., Davis, M., Tsuberi, B.-Z., Pikarsky, E., Pagano, M., & Ben‐Neriah, Y. (2010) · Genes & Development · doi:10.1101/gad.551610 · Cited by 41
The ubiquitin proteasome system and its involvement in cell death pathways
Bernassola, F., Ciechanover, A. J., & Melino, G. (2009) · Cell Death and Differentiation · doi:10.1038/cdd.2009.189 · Cited by 43
Structural and Functional Basis of JAMM Deubiquitinating Enzymes in Disease
Pan, X., Wu, S., Wei, W., Chen, Z., Wu, Y., & Gong, K. (2022) · Biomolecules · doi:10.3390/biom12070910 · Cited by 47
Zhang, S., Tan, J., Lai, Z., Li, Y., Pang, J., Xiao, J., Huang, Z., Zhang, Y., Ji, H., & Lai, Y. (2014) · Journal of Chemical Information and Modeling · doi:10.1021/ci5002058 · Cited by 41
AXR1 promotes the Arabidopsis cytokinin response by facilitating ARR5 proteolysis
Li, Y., Kurepa, J., & Smalle, J. (2012) · The Plant Journal · doi:10.1111/tpj.12098 · Cited by 41
Erba, H. P. (2014) · Leukemia Research · doi:10.1016/j.leukres.2014.11.027 · Cited by 40
Kumar, A., Ito, A., Hirohama, M., Yoshida, M., & Zhang, K. Y. J. (2016) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2016.01.030 · Cited by 40
Ma, H., Zhuang, C., Xu, X., Li, J., Wang, J., Min, X., Zhang, W., Zhang, H., & Miao, Z. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.03.076 · Cited by 40
Zhao, H., Iqbal, N. J., Sukrithan, V., Nicholas, C., Xue, Y., Yu, C., Locker, J. D., Zou, J., Schwartz, E. L., & Zhu, L. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-2400 · Cited by 43
Antimicrobial Peptide Reverses ABCB1-Mediated Chemotherapeutic Drug Resistance
Luo, X., Teng, Q., Dong, J., Yang, D., Wang, M., Dessie, W., Qin, J., Lei, Z., Wang, J., Qin, Z., et al. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01208 · Cited by 42
Kim, K., Pröbstel, A., Baumann, R., Dyckow, J., Landefeld, J., Kogl, E., Madireddy, L., Loudermilk, R. P., Eggers, E. L., Singh, S., et al. (2020) · Brain · doi:10.1093/brain/awaa421 · Cited by 42
Yu, X., Xu, J., Cahuzac, K. M., Xie, L., Shen, Y., Chen, X., Liu, J., Parsons, R. E., & Jin, J. J. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c01454 · Cited by 42
PCNA-Dependent Cleavage and Degradation of SDE2 Regulates Response to Replication Stress
Jo, U., Cai, W., Wang, J., Yoojin, K., D’Andrea, A. D., & Kim, H. (2016) · PLoS Genetics · doi:10.1371/journal.pgen.1006465 · Cited by 40
Ai, T.-J., Sun, J., Du, L., Shi, C., Li, C., Sun, X., Liu, Y., Li, L., Xia, Z., Jia, L., et al. (2017) · Cell Death and Differentiation · doi:10.1038/cdd.2017.160 · Cited by 40
Targeting the neddylation pathway in cells as a potential therapeutic approach for diseases
Ying, J., Zhang, M., Qiu, X., & Yu, L. (2018) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-018-3541-8 · Cited by 40
Dedifferentiation by adenovirus E1A due to inactivation of Hippo pathway effectors YAP and TAZ
Zemke, N. R., Gou, D., & Berk, A. J. (2019) · Genes & Development · doi:10.1101/gad.324814.119 · Cited by 41
Biomarkers for RBM39 degradation in acute myeloid leukemia
Hsiehchen, D., Goralski, M., Kim, J., Xie, Y., & Nijhawan, D. (2020) · Leukemia · doi:10.1038/s41375-020-0729-9 · Cited by 39
Zeng, R., Lv, B., Lin, Z., Chu, X., Xiong, Y., Knoedler, S. A., Cao, F., Lin, C., Chen, L., Yu, C., et al. (2024) · Bioactive Materials · doi:10.1016/j.bioactmat.2023.12.025 · Cited by 65
ZAK activation at the collided ribosome
Huso, V. L., Niu, S., Catipovic, M. A., Saba, J. A., Denk, T., Park, E., Cheng, J., Berninghausen, O., Becker, T. A., Green, R., et al. (2025) · Nature · doi:10.1038/s41586-025-09772-8 · Cited by 42
Lu, P. Z., Liu, X., Yuan, X., He, M., Wang, Y., Zhang, Q., & Ouyang, P. (2016) · ACS Chemical Biology · doi:10.1021/acschembio.6b00159 · Cited by 39
Kuang, P., Tan, M., Zhou, W., Zhang, Q., & Sun, Y. N. (2016) · Scientific Reports · doi:10.1038/srep37441 · Cited by 41
Vangl2 interaction plays a role in the proteasomal degradation of Prickle2
Nagaoka, T., Furuse, M., Ohtsuka, T., Tsuchida, K., & Kishi, M. (2019) · Scientific Reports · doi:10.1038/s41598-019-39642-z · Cited by 39
Regulation of MAGE‐A3/6 by the CRL4‐DCAF12 ubiquitin ligase and nutrient availability
Ravichandran, R., Kodali, K., Peng, J., & Potts, P. R. (2019) · EMBO Reports · doi:10.15252/embr.201847352 · Cited by 44
A cullin-RING ubiquitin ligase targets exogenous α-synuclein and inhibits Lewy body–like pathology
Gerez, J., Prymaczok, N. C., Rockenstein, E. M., Herrmann, U., Schwarz, P., Adame, A., Enchev, R. I., Courthéoux, T., Boersema, P. J., Riek, R., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aau6722 · Cited by 41
Post-translational modification of Parkin and its research progress in cancer
Ding, D., Ao, X., Liu, Y., Wang, Y., Fa, H., Wang, M.-Y., He, Y., & Wang, J. (2019) · 癌症:英文版 · doi:10.1186/s40880-019-0421-5 · Cited by 40
Zhou, M., Zhao, Q., Wu, Y., Feng, S., Wang, D., Zhang, Y., & Wang, S. (2020) · AAPS PharmSciTech · doi:10.1208/s12249-019-1604-8 · Cited by 42
Adenovirus-mediated ubiquitination alters protein–RNA binding and aids viral RNA processing
Herrmann, C., Dybas, J. M., Liddle, J. C., Price, A. M., Hayer, K. E., Lauman, R., Purman, C. E., Charman, M., Kim, E. T., Garcia, B. A., et al. (2020) · Nature Microbiology · doi:10.1038/s41564-020-0750-9 · Cited by 40
Virtual Screening of Natural Products Database
Luís, J., Barros, R. P. C., de Sousa, N. F., Muratov, E. N., Scotti, L., & Scotti, L. (2020) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557520666200730161549 · Cited by 40
Progress Update in Pediatric Renal Tumors
Jain, J., Sutton, K. S., & Hong, A. L. (2021) · Current Oncology Reports · doi:10.1007/s11912-021-01016-y · Cited by 39
Chen, W., Luo, B., Gao, N., Li, H., Wang, H., Li, L., Cui, W., Zhang, L., Sun, D., Liu, F., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci136956 · Cited by 40
FBXO6-mediated RNASET2 ubiquitination and degradation governs the development of ovarian cancer
Ji, M., Zhao, Z., Li, Y., Xu, P., Shi, J., Li, Z., Wang, K., Huang, X., & Liu, B. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03580-4 · Cited by 41
Lin, Y., Chen, Y., Feng, W., Hua, R., Zhang, J., Huo, Y., Jiang, H., Yin, B., & Yang, X. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03549-3 · Cited by 39
Self-citationAndérica‐Romero, A. C., Hernández‐Damián, J., Vázquez-Cervantes, G. I., Torres, I., & Pedraza‐Chaverrí, J. (2016) · Redox Biology · doi:10.1016/j.redox.2016.02.008 · Cited by 39
Emerging Cancer Therapeutic Targets in Protein Homeostasis
Bastola, P., Oien, D. B., Cooley, M., & CHIEN, J. R. (2018) · The AAPS Journal · doi:10.1208/s12248-018-0254-1 · Cited by 40
Metadata
- Authors
- Soucy, T. A., Smith, P. G., Milhollen, M. A., Berger, A. J., Gavin, J. M., Adhikari, S., Brownell, J. E., Burke, K. E., Cardin, D. P., Critchley, S., Cullis, C. A., Doucette, A., Garnsey, J. J., Gaulin, J. L., Gershman, R. E., Lublinsky, A. R., McDonald, A., Mizutani, H., Narayanan, U., Olhava, E. J., Peluso, S., Rezaei, M., Sintchak, M. D., Talreja, T., Thomas, M. P., Traore, T., Vyskocil, S., Weatherhead, G. S., Yu, J., Zhang, J., Dick, L. R., Claiborne, C. F., Rolfe, M., Bolen, J. B., & Langston, S. P.
- Affiliations
- Takeda Oncology (United States) (US)
- Corresponding author
- Soucy, Teresa A.
- ORCID
- Venue
- Nature
- Published
- 2009-04
- Volume
- 458
- Issue
- 7239
- Pages
- 732-736
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2076194625
- Cited by
- 1,990
- References
- 46
- Citations by year
- 2026: 110 · 2025: 120 · 2024: 156 · 2023: 126 · 2022: 137 · 2021: 155 · 2020: 170 · 2019: 149 · 2018: 112 · 2017: 105 · 2016: 108 · 2015: 98 · 2014: 99 · 2013: 100 · 2012: 100
- FWCI
- 32.71
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- NEDD8-activating enzyme, MLN4924, cullin-RING ubiquitin ligases, ubiquitin-proteasome system, proteasome inhibitors, cancer cell death, tumor xenografts, small molecule inhibitors, antitumour activity
- MeSH terms
- NEDD8 Protein, Animals, Antineoplastic Agents, Cells, Cultured, Cyclopentanes, Enzyme Inhibitors, Female, Humans, Neoplasms, Pyrimidines, Transplantation, Heterologous, Ubiquitins, Ubiquitin-Activating Enzymes, Cullin Proteins, Cell Line, Tumor, Mice, Proteasome Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.